MariGen

About Kerecis

Kerecis is a commercial-stage medical device company pioneering the use of intact, minimally processed fish skin as a biological scaffold for tissue regeneration. Its core technology leverages the structural similarity of North Atlantic cod skin to human skin and the absence of known viral transmission risks, allowing for gentle processing that preserves natural lipids and extracellular matrix components. The company has achieved significant commercial traction, particularly in the US wound care market, with products reimbursed by CMS and private payers, and is expanding its portfolio into surgical and plastic reconstructive applications. Founded in 2006 and headquartered in Reykjavik, Iceland, Kerecis combines a unique biologic platform with a strong sustainability narrative.

Therapeutic Areas